BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maes D, Boyen F, Devriendt B, Kuhnert P, Summerfield A, Haesebrouck F. Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs. Vet Res 2021;52:67. [PMID: 33964969 DOI: 10.1186/s13567-021-00941-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Scalisi N, Kuhnert P, Amado MEV, Overesch G, Stärk KD, Ruggli N, Jores J. Seroprevalence of Mycoplasma hyopneumoniae in sows fifteen years after implementation of a control programme for enzootic pneumonia in Switzerland. Veterinary Microbiology 2022;270:109455. [DOI: 10.1016/j.vetmic.2022.109455] [Reference Citation Analysis]
2 Li Z, Wang Y, Zhang Y, Tang X, Wang X, Liu W, Qian Y, Zhu Y, Chen H, Tan C. Attenuation of Mycoplasma hyopneumoniae Strain ES-2 and Comparative Genomic Analysis of ES-2 and Its Attenuated Form ES-2L. Front Vet Sci 2021;8:696262. [PMID: 34235206 DOI: 10.3389/fvets.2021.696262] [Reference Citation Analysis]
3 Garcia-Morante B, Maes D, Sibila M, Betlach AM, Sponheim A, Canturri A, Pieters M. Improving Mycoplasma hyopneumoniae diagnostic capabilities by harnessing the infection dynamics. Vet J 2022;:105877. [PMID: 35901923 DOI: 10.1016/j.tvjl.2022.105877] [Reference Citation Analysis]
4 Broto A, Gaspari E, Miravet-Verde S, Dos Santos VAPM, Isalan M. A genetic toolkit and gene switches to limit Mycoplasma growth for biosafety applications. Nat Commun 2022;13:1910. [PMID: 35393441 DOI: 10.1038/s41467-022-29574-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhu X, Zhaoyang Zhang, Bin Jia, Yuan Y. Current advances of biocontainment strategy in synthetic biology. Chinese Journal of Chemical Engineering 2022. [DOI: 10.1016/j.cjche.2022.07.019] [Reference Citation Analysis]
6 Stingelin GM, Mechler-dreibi ML, Storino GY, Sonalio K, Almeida HMDS, Petri FAM, de Oliveira LG. Chemotherapeutic Strategies with Valnemulin, Tilmicosin, and Tulathromycin to Control Mycoplasma hyopneumoniae Infection in Pigs. Antibiotics 2022;11:893. [DOI: 10.3390/antibiotics11070893] [Reference Citation Analysis]
7 Biebaut E, Chantziaras I, Boyen F, Devriendt B, Haesebrouck F, Gomez-Duran CO, Maes D. Influence of parity and reproductive stage on the prevalence of Mycoplasma hyopneumoniae in breeding animals in belgian farrow-to-finish pig herds. Porcine Health Manag 2022;8:26. [PMID: 35681230 DOI: 10.1186/s40813-022-00267-w] [Reference Citation Analysis]
8 Li G, Shu J, Jin J, Shu J, Feng H, Chen J, He Y. Development of a Multi-Epitope Vaccine for Mycoplasma hyopneumoniae and Evaluation of Its Immune Responses in Mice and Piglets. IJMS 2022;23:7899. [DOI: 10.3390/ijms23147899] [Reference Citation Analysis]